Finance

Lists
301201:SHE
Chengda Pharmaceuticals Co Ltd
CNÂ¥26.53
+0.04%
(+0.010) 1D
Oct 21, 3:02:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301201...
Open
CNÂ¥26.72
High
CNÂ¥27.22
Low
CNÂ¥26.31
Mkt. cap
3.97B
Avg. vol.
5.95M
Volume
2.90M
Dividend
0.75%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 15, 2026
52-wk high
CNÂ¥65.03
52-wk low
CNÂ¥24.80
EPS
-CNÂ¥0.15
Shares outstanding
154.71M
No. of employees
694
Open
CNÂ¥26.72
High
CNÂ¥27.22
Low
CNÂ¥26.31
Mkt. cap
3.97B
Avg. vol.
5.95M
Volume
2.90M
Dividend
0.75%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 15, 2026
52-wk high
CNÂ¥65.03
52-wk low
CNÂ¥24.80
EPS
-CNÂ¥0.15
Shares outstanding
154.71M
No. of employees
694
News stories
From web sources and news partners
About Chengda Pharmaceuticals Co Ltd
CEO-
Employees694
Founded1980
Headquarters-
SectorPharmaceutical industry
Websitechengdapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
102.64M
121.28M
128.24M
127.25M
Cost of goods sold
52.60M
113.56M
85.75M
95.08M
Cost of revenue
52.60M
113.56M
85.75M
95.08M
Research and development expenses
10.21M
9.90M
11.01M
11.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.52M
23.17M
24.43M
23.37M
Operating expense
40.48M
37.27M
37.21M
36.11M
Total operating expenses
93.08M
150.83M
122.97M
131.19M
Operating income
9.56M
-29.55M
5.27M
-3.94M
Other non operating income
-1.13M
1.14M
-2.16M
2.12M
EBT including unusual items
5.04M
-31.24M
9.36M
-7.22M
EBT excluding unusual items
11.76M
-26.99M
2.93M
-5.26M
Income tax expense
1.24M
-2.48M
2.34M
-2.50M
Effective tax rate
24.64%
7.95%
24.99%
34.54%
Other operating expenses
-2.68M
4.07M
237.04K
1.88M
Net income
3.95M
-28.70M
7.00M
-4.70M
Net profit margin
3.85%
-23.66%
5.46%
-3.70%
Earnings per share
-
-
-
-
Interest and investment income
4.09M
3.82M
211.37K
216.08K
Interest expense
-
-2.28M
-398.90K
-376.62K
Net interest expenses
4.09M
1.54M
-187.53K
-160.54K
Depreciation and amortization charges
-
-
-
-
EBITDA
21.27M
-11.42M
23.40M
14.74M
Gain or loss from assets sale
37.33K
-37.33K
-
52.48K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps